U.S. Online Retail and Ecommerce Stock News

If you are wondering whether Darling Ingredients at US$63.77 is offering fair value right now or if the price has already run ahead of the story, this article breaks down what the market may be pricing in. The stock has returned 6.0% over the last 7 days, 2.6% over the last month, 69.4% year to date, and 95.9% over the last year, figures that can change how investors think about both upside and risk. Recent news coverage has focused on how the company fits into broader themes in food, waste...

Wave Life Sciences (WVE) drew investor attention after reporting first quarter 2026 results, with sales of US$38.25 million, a net loss of US$26.09 million, and progress across several RNA based clinical programs. See our latest analysis for Wave Life Sciences. Despite the earnings beat and clinical updates, the recent 7.17% 1 month share price return to US$7.32 comes after a much steeper 43.43% 3 month share price decline. The 3 year total shareholder return of 83.46% contrasts with a 9.63%...

Dolby Laboratories (DLB) has put up a solid Q2 2026 scorecard, with revenue of US$395.6 million and basic EPS of US$1.00, setting a clear marker for how the year is shaping up. Over the past few quarters the company has seen revenue move from US$356.999 million in Q1 2025 to US$369.561 million in Q2 2025, then to US$346.706 million in Q1 2026 and now US$395.63 million, while basic EPS tracked from US$0.71 to US$0.95, then US$0.56 and now just under US$1.00. With a trailing twelve month net...

For investors considering whether H.B. Fuller is currently priced attractively or if the recent share price leaves limited potential upside, this article focuses on what the current valuation suggests. The stock last closed at US$59.95, with a 12.1% return over the past year. However, recent 7-day and 30-day returns of 4.6% and 4.0% declines, along with a small 0.6% decline year to date, indicate that sentiment has been more cautious lately. Recent coverage has centered on how H.B. Fuller is...

Why Core Scientific’s latest financing and Texas build out matter for stock watchers Core Scientific (CORZ) is in focus after its financing arm completed a US$3.3b senior secured notes offering due 2031, alongside plans to expand its Pecos, Texas campus for high density AI colocation. See our latest analysis for Core Scientific. At a share price of US$20.35, Core Scientific has recorded a 33.01% 1 month share price return and a 27.27% year to date share price return, while its 1 year total...

In recent days, Ovintiv has attracted growing attention as analysts broadly raised their earnings estimates for the next quarter and full year, while major institutional holders such as Vanguard disclosed multi-million-share, passive stakes in the company. This combination of upgraded earnings expectations, continued bullish analyst views, and concentrated institutional ownership has sharpened the focus on how Ovintiv’s fundamentals align with differing assessments of its intrinsic value and...

Critical Metals (NasdaqGM:CRML) has increased its stake in Tanbreez Mining Greenland to 92.5%. The company has entered into an agreement with European Lithium to acquire the remaining minority interest. The transaction moves Critical Metals closer to full ownership of one of the largest rare earth projects globally. For investors watching the rare earths space, Critical Metals, ticker NasdaqGM:CRML, now holds a 92.5% stake in Tanbreez Mining Greenland and has a path toward full control. The...

What recent performance signals about Regeneron Pharmaceuticals (REGN) With no single headline event driving Regeneron Pharmaceuticals (REGN) today, the stock’s recent performance and current fundamentals offer a useful starting point if you are tracking large cap US biotech names. Regeneron closed at US$701.42, with shares showing a 0.8% decline over the past day and a 6.7% decline over the past week. The stock is also down about 9.8% over the past month and 5.4% over the past 3 months,...

Bank of New York Mellon Corporation (BK) has been drawing attention after its recent share performance, with returns of about 11% over the past 3 months and roughly 14% year to date. See our latest analysis for Bank of New York Mellon. The recent 10.6% 30 day share price return, on top of a 14.3% year to date move, sits against a much stronger backdrop, with 1 year total shareholder return of 65.9% and very large 3 year gains. This suggests momentum has been building over time, even if the...

Builders FirstSource (BLDR) just posted Q1 2026 results with revenue of US$3.3b and a net loss of US$47.4m, translating to a basic EPS loss of US$0.43 as investors reassess how earnings power is tracking into the new year. The company has seen quarterly revenue move from US$3.7b and EPS of US$0.85 in Q1 2025 to US$3.3b and a loss per share in the latest quarter, which puts the spotlight firmly on how quickly profitability can be rebuilt from here. With trailing profit margins thinner than a...

If you are wondering whether PepsiCo's current share price offers fair value or a margin of safety, the numbers behind the stock can help frame that decision. At a last close of US$157.41, PepsiCo has recorded returns of 1.3% over 7 days, 1.8% over 30 days, 10.7% year to date, 22.4% over 1 year, negative 10.3% over 3 years and 26.3% over 5 years. This gives you several different entry points to think about. Recent coverage has focused on PepsiCo's role as a global beverages and snacks...

DISH Network, now owned by EchoStar, recently restored 226 local channels in 113 U.S. markets after reaching a long-term carriage agreement with Gray Media, ensuring continued access to major broadcast networks for its subscribers. This resolution reduces service disruption risk for EchoStar’s pay-TV business, supporting customer retention and underpinning the broader satellite and wireless connectivity platform it is building. We’ll now examine how restoring these local channels, and the...

Wondering whether Preformed Line Products at around US$333 per share still offers value, or if the best of the opportunity is already behind it? This breakdown is designed to help you make sense of the current price. The stock has been volatile recently, with a 5.0% decline over the last 7 days, a 14.5% gain across the past month, a 57.5% return year to date, and a 143.9% return over the last 12 months. These moves have put the company back on many investors' radars, especially as they...

Wondering whether LSB Industries at US$14.77 still offers value after a strong run? This article focuses squarely on what the current price might mean for you. The stock has returned 2.6% over the last 7 days, is down 1.1% over 30 days, and shows YTD returns of 72.3% and 123.8% over 1 year that may signal changing views on its potential and risk. Recent coverage has focused on LSB Industries' share price performance and how investors are reacting to company updates. This helps explain some...

Stryker (SYK) opened 2026 with Q1 revenue of US$6.0b and basic EPS of US$1.95, while trailing twelve month figures stood at US$25.3b in revenue and basic EPS of US$8.72, giving investors a clear read on the latest run rate. The company has seen quarterly revenue move from US$5.9b in Q1 2025 to US$6.0b in Q1 2026, with basic EPS over that period shifting from US$1.71 to US$1.95, and those results sit against a backdrop of earnings growth that has outpaced revenue and supported firmer net...

Macerich (MAC) has drawn fresh attention after recent share performance, with the stock showing gains over the past month and past 3 months. This has prompted investors to reassess its valuation and income profile. See our latest analysis for Macerich. The recent 10.94% 1 month share price return and 16.09% year to date share price return, alongside a 47.03% 1 year total shareholder return and very large 3 year total shareholder return, point to momentum that buyers are still willing to test...

Air Products and Chemicals (APD) has put down another solid quarter, with Q2 2026 revenue of US$3.2 billion and basic EPS of US$3.19, supported by net income of US$710.4 million. The company has seen quarterly revenue move from US$2,916.2 million in Q2 2025 to US$3,171.8 million in Q2 2026, while basic EPS shifted from a loss of US$7.77 per share in Q2 2025 to a profit of US$3.19. This sets up the latest release as a clean read on current profitability. With trailing net margins running at...

nCino (NCNO) is back in focus after Raiffeisenbankengruppe Oesterreich chose its platform to run the entire corporate lending lifecycle, a move investors are weighing alongside optimism around the next earnings release. See our latest analysis for nCino. The recent client win in Europe and leadership change in APAC come as the stock trades at US$18.13, with a 1 month share price return of 9.41% but a year to date share price decline of 26.45%. This points to short term momentum alongside a...

In the first quarter of 2026, SoFi Technologies reported net income of US$166.73 million on about US$1.1 billion of revenue, with basic earnings per share from continuing operations rising to US$0.13 and record loan originations of US$12.2 billion. Despite this strong operational performance, including 14.7 million total members and continued profitability, investor attention has focused on rising net charge‑offs of US$201.64 million and weakness in the Technology Platform after the loss of...

Jazz Pharmaceuticals (JAZZ) is back in focus after US regulators accepted a priority review of its supplemental biologics application for Ziihera in HER2-positive advanced gastroesophageal cancers, supported by pivotal Phase 3 HERIZON-GEA-01 data. See our latest analysis for Jazz Pharmaceuticals. Alongside the FDA priority review and a busy oncology conference schedule, Jazz Pharmaceuticals’ 1 month share price return of 7.68% and 90 day share price return of 23.24% feed into a 1 year total...

International Paper (IP) opened 2026 with Q1 revenue of US$6.0 billion and basic EPS of US$0.14, setting a more stable starting point after a volatile run of quarterly results. Over recent periods, the company has seen revenue move from US$3.9 billion in Q4 2024 to just over US$6.0 billion in Q4 2025. Basic EPS has swung from a profit of US$0.25 in Q4 2024 to a loss of US$4.48 in Q4 2025 and then back to a modest profit in Q1 2026, keeping investor attention firmly on the direction of margins...

Uber Technologies (NYSE:UBER) has agreed to acquire Hong Kong based FlyTaxi, expanding its presence in the city’s regulated taxi market. A U.S. federal jury in North Carolina recently found Uber directly liable for a driver’s assault on a passenger, creating a new legal benchmark for gig economy platforms. These developments arrive with Uber shares at $75.12, following a 4.8% return over the past 30 days and a 99.0% return over 3 years. For investors tracking Uber Technologies, the...

Rezolve AI’s recent stock performance in context Rezolve AI (RZLV) has drawn attention after a recent move in its share price, prompting investors to reassess how its current valuation lines up with recent returns and the company’s latest reported financial profile. Over the past month, Rezolve AI’s share price return sits at about a 14.7% decline, while the past 3 months show a 3.5% gain and the past year reflects an 18.1% total return. See our latest analysis for Rezolve AI. Rezolve AI’s...

In April 2026, Motorola Solutions’ Silvus Technologies subsidiary launched the handheld FASST 6000 Spectrum Sensor and expanded CommandCentral Aware, adding mission-based workspaces and embedded AI to enhance real-time crime center and RF spectrum intelligence capabilities. Together with investors highlighting resilient demand in Motorola Solutions’ core Land Mobile Radio business and growing adoption of its advanced public safety technologies, these product advances reinforce the company’s...